Belgian multicenter study into von Willebrand disease (B-Will study): first results

被引：0
|
作者：
Vangenechten, I [1 ]
Jochmans, K. [2 ]
Devreese, K. [3 ]
Motte, S. [4 ]
Gadisseur, A. [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Hematol, Hemostasis Unit, Edegem, Belgium
[2] Univ Hosp Brussels, Dept Hematol, Brussels, Belgium
[3] Univ Hosp Gent, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium
[4] Univ Hosp ULB Erasme, Dept Vasc Med, Brussels, Belgium
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO668-TUE
引用
收藏
页码：749 / 749
页数：1
相关论文
共 50 条
  • [1] Incidence and determinants of bleeding in von Willebrand disease: Results of the first prospective multicenter study on 814 Italian patients
    Federici, A. B.
    Bucciarelli, P.
    Castaman, G.
    Mazzucconi, M. G.
    Morfini, M.
    Rocino, A.
    Schiavoni, M.
    Rodeghiero, F.
    Mannucci, P. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 28 - 28
  • [2] Incidence and determinants of bleeding in Von Willebrand disease: Results ofthe first prospective multicenter study on 814 Italian patients
    Federici, A. B.
    Bucciarelli, P.
    Castaman, G.
    Mazzucconi, M. G.
    Morfini, M.
    Rocino, A.
    Schiavoni, M.
    Rodeghiero, F.
    Mannucci, P. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 328 - 328
  • [3] Incidence and determinants of bleeding in different types of von Willebrand disease: Results of the first prospective multicenter study on 814 Italian patients.
    Federici, Augusto B.
    Bucciarelli, Paolo
    Castaman, Giancarlo
    Mazzucconi, Maria G.
    Morfini, Massimo
    Rocino, Angiola
    Schiavoni, Mario
    Rodeghiero, Francesco
    Mannucci, Pier M.
    BLOOD, 2007, 110 (11) : 219A - 219A
  • [4] Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Wang, Michael
    Wynn, Tung
    Baptista, Jovanna
    Wang, Yi
    Zhang, Jingmei
    Mellgard, Bjorn
    Ozen, Gulden
    BLOOD, 2022, 140 (02) : 89 - 98
  • [5] Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study
    Mannucci, PM
    Chediak, J
    Hanna, W
    Byrnes, J
    Ledford, M
    Ewenstein, BM
    Retzios, AD
    Kapelan, BA
    Schwartz, RS
    Kessler, C
    BLOOD, 2002, 99 (02) : 450 - 456
  • [6] Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
    Tosetto, A.
    Rodeghiero, F.
    Castaman, G.
    Bernardi, M.
    Bertoncello, K.
    Goodeve, A.
    Federici, A. B.
    Batlle, J.
    Meyer, D.
    Mazurier, C.
    Goudemand, J.
    Eikenboom, J.
    Schneppenheim, R.
    Budde, U.
    Ingerslev, J.
    Vorlova, Z.
    Habart, D.
    Holmberg, L.
    Lethagen, S.
    Pasi, J.
    Hill, F.
    Peake, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 715 - 721
  • [7] Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study
    Krahforst, Alexander
    Yadegari, Hamideh
    Pavlova, Anna
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Poetzsch, Bernd
    Scholz, Ute
    Richter, Heinrich
    Trobisch, Heiner
    Liebscher, Karin
    Olivieri, Martin
    Trautmann-Grill, Karolin
    Knoefler, Ralf
    Halimeh, Susan
    Oldenburg, Johannes
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (11) : 3010 - 3034
  • [8] First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease
    Baaij, Marije
    van Galen, Karin P. M.
    Urbanus, Rolf T.
    Nigten, Jeannet
    Eikenboom, Jeroen H. C.
    Schutgens, Roger E. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (03) : 424 - 427
  • [9] Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis -: Results from a multicenter study in 47 patients
    Srámek, A
    Bucciarelli, P
    Federici, AB
    Mannucci, PM
    De Rosa, V
    Castaman, G
    Morfini, M
    Mazzucconi, MG
    Rocino, A
    Schiavoni, M
    Scaraggi, FA
    Reiber, JHC
    Rosendaal, FR
    CIRCULATION, 2004, 109 (06) : 740 - 744
  • [10] Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
    Federici, AB
    Mazurier, C
    Berntorp, E
    Lee, CA
    Scharrer, I
    Goudemand, J
    Lethagen, S
    Nitu, I
    Ludwig, G
    Hilbert, L
    Mannucci, PM
    BLOOD, 2004, 103 (06) : 2032 - 2038
12345